The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line

Nonsteroidal Antiinflammatory Drugs and Bladder Cancer: A Pooled Analysis

(2011) S. E. Daugherty et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Indomethacin and SC236 enhance the cytotoxicity of doxorubicin in human hepatocellular carcinoma cells via inhibiting P-glycoprotein and MRP1 expression

(2011) Cai-Guo Ye et al.   CANCER LETTERS

EAU Guidelines on Non–Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

(2011) Marko Babjuk et al.   EUROPEAN UROLOGY

Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines

(2010) Fatemeh Kalalinia et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

(2009) Per-Uno Malmström et al.   EUROPEAN UROLOGY

Multidrug Resistance in a Urothelial Cancer Cell Line After 1-Hour Mitomycin C Exposure

(2009) Narendrakumar Birare et al.   JOURNAL OF UROLOGY

Cyclooxygenase Inhibitors Down Regulate P-glycoprotein in Human Colorectal Caco-2 Cell Line

(2008) Afraa Zrieki et al.   PHARMACEUTICAL RESEARCH